Serum insulin-like growth factors and mortality in localised and advanced clinically detected prostate cancer

Cancer Causes and Control

Volumn 23, Issue 2, 2012, Pages 347-354

  Rowlands, Mari Anne ^a   Holly, Jeff M P ^a   Hamdy, Freddie ^b   Phillips, Joshua ^c   Goodwin, Louise ^c   Marsden, Gemma ^b   Gunnell, David ^a   Donovan, Jenny ^a   Neal, David E ^d   Martin, Richard M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Insulin like growth factors; Mortality; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TUMOR MARKER;

ADVANCED CANCER; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FOLLOW UP; GLEASON SCORE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SMOKING HABIT; TUMOR LOCALIZATION;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84856722993     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9883-8     Document Type: Article

References (33)

1. DM Parkin FI Bray SS Devesa 2001 Cancer burden in the year 2000. The global picture Eur J Cancer 37 4 66 10.1016/S0959-8049(01)00267-2
2. JE Johansson L Holmberg S Johansson R Bergstrom HO Adami 1997 Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden JAMA 277 467 471 9020270 10.1001/jama.1997.03540300035030 1:STN:280:DyaK2s7nt1WrtA%3D%3D (Pubitemid 27074330)
3. J Concato D Jain E Uchio H Risch WW Li CK Wells 2009 Molecular markers and death from prostate cancer Ann Intern Med 150 595 603 19414838
4. K Fall H Garmo O Andren A Bill-Axelson J Adolfsson HO Adami JE Johansson L Holmberg 2007 Prostate-specific antigen levels as a predictor of lethal prostate cancer JNCI J Natl Cancer Inst 99 526 532 10.1093/jnci/djk110 (Pubitemid 47073555)
5. C Metcalfe K Tilling M Davis JA Lane RM Martin H Kynaston P Powell DE Neal F Hamdy JL Donovan 2009 Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study Br J Cancer 101 390 394 19603015 10.1038/sj.bjc.6605181 1:STN:280:DC%2BD1MrhslWntg%3D%3D
6. M Pollak 2008 Insulin, insulin-like growth factors and neoplasia Best Pract Res Clin Endocrinol Metab 22 625 638 18971123 10.1016/j.beem.2008.08.004 1:CAS:528:DC%2BD1cXht12rtr7N
7. M Rowlands D Gunnell R Harris LJ Vatten JMP Holly RM Martin 2009 Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis Int J Cancer 124 2416 2429 19142965 10.1002/ijc.24202 1:CAS:528:DC%2BD1MXltFaqt7w%3D
8. AW Roddam NE Allen P Appleby TJ Key L Ferrucci HB Carter EJ Metter C Chen NS Weiss A Fitzpatrick AW Hsing JV Lacey Jr K Helzlsouer S Rinaldi E Riboli R Kaaks JAMJ Janssen MF Wildhagen FH Schroder EA Platz M Pollak E Giovannucci C Schaefer CP Quesenberry Jr JH Vogelman G Severi DR English GG Giles P Stattin G Hallmans M Johansson JM Chan P Gann SE Oliver JM Holly J Donovan F Meyer I Bairati P Galan 2008 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies Ann Intern Med 149 461 471 18838726
9. E Petridou A Salkidou N Dessypris M Moustaki C Mantzoros E Spanos D Trichopoulos 2001 Insulin-like growth factor binding protein-3 predicts survival from acute childhood leukemia Oncology 60 252 257 11340377 10.1159/000055326 1:CAS:528:DC%2BD3MXjvVWqtLs%3D (Pubitemid 32424531)
10. RL Rocha SG Hilsenbeck JG Jackson CL VanDenBerg C Weng AV Lee D Yee 1997 Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival Clin Cancer Res 3 103 109 9815544 1:STN:280:DyaK1M%2FjsFamuw%3D%3D (Pubitemid 27079451)
11. K Wakai Y Ito K Suzuki A Tamakoshi N Seki M Ando K Ozasa Y Watanabe T Kondo Y Nishino Y Ohno 2002 Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study Jpn J Cancer Res 93 1279 1286 12495466 10.1111/j.1349-7006.2002.tb01235.x 1:CAS:528: DC%2BD3sXht12qsb0%3D (Pubitemid 36104866)
12. H Yu MA Levesque MJ Khosravi A Papanastasiou-Diamandi GM Clark EP Diamandis 1998 Insulin-like growth factor binding protein-3 and breast cancer survival Int J Cancer 79 624 628 9842972 10.1002/(SICI)1097-0215(19981218)79: 6<624::AID-IJC12>3.0.CO;2-9 1:STN:280:DyaK1M%2FlslWjtA%3D%3D (Pubitemid 28549475)
13. AS Parker JC Cheville C Lohse JR Cerhan ML Blute 2003 Expression of insulin-like growth factor I receptor and survival in patients with clear cell renal cell carcinoma J Urol 170 420 424 12853790 10.1097/01.ju.0000071474.70103. 92 1:CAS:528:DC%2BD3sXlsVKgtb0%3D (Pubitemid 36870215)
14. Y Lin A Tamakoshi S Kikuchi K Yagyu Y Obata T Ishibashi T Kawamura Y Inaba M Kurosawa Y Motohashi Y Ohno 2004 Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death Int J Cancer 110 584 588 15122592 10.1002/ijc.20147 1:CAS:528: DC%2BD2cXktlKktbY%3D (Pubitemid 38658024)
15. JV Vadgama Y Wu G Datta H Khan R Chillar 1999 Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women Oncology 57 330 340 10575321 10.1159/000012052 1:CAS:528:DyaK1MXnvVKktb8%3D
16. Greene FL, Page DL (2002) Genitourinary sites. Prostate. In: Green FL, Page DL, Fleming ID, Fritz AD, Balch CM, Haller DG, Morrow M (eds) AJCC cancer staging manual. Springer, New York, pp 309-317
17. A Juul K Main WF Blum J Lindholm MB Ranke NE Skakkebaek 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients Clin Endocrinol 41 85 93 10.1111/j.1365-2265. 1994.tb03788.x 1:STN:280:DyaK2czis1eqtw%3D%3D (Pubitemid 24232532)
18. J Holly C Perks 2006 The role of insulin-like growth factor binding proteins Neuroendocrinology 83 154 160 17047378 10.1159/000095523 1:CAS:528:DC%2BD28XhtV2hu7rI (Pubitemid 44578867)
19. R Fukuda K Hirota F Fan YD Jung LM Ellis GL Semenza 2002 Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells J Biol Chem 277 38205 38211 12149254 10.1074/jbc.M203781200 1:CAS:528:DC%2BD38Xns1Cnsrw%3D (Pubitemid 35154674)
20. MP Playford D Bicknell WF Bodmer VM Macaulay 2000 Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of B-catenin Proc Natl Acad Sci USA 97 12103 12108 11035789 10.1073/pnas.210394297 1:CAS:528:DC%2BD3cXnvVSgtLo%3D
21. JI Jones D Clemmons 1995 Insulin-like growth factors and their binding proteins: biological actions Endocr Rev 16 3 34 7758431 1:CAS:528: DyaK2MXltlKhu7g%3D
22. WA Satariano KE Ragland SK Van Den Eeden 1998 Cause of death in men diagnosed with prostate carcinoma Cancer 83 1180 1188 9740084 10.1002/(SICI)1097-0142(19980915)83:6<1180::AID-CNCR18>3.0.CO;2-1 1:STN:280:DyaK1cvhtVyjsg%3D%3D (Pubitemid 28419072)
23. N Friedrich R Haring M Nauck J Ludemann D Rosskopf E Spilcke-Liss SB Felix M Dorr G Brabant H Volzke H Wallaschofski 2009 Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations J Clin Endocrinol Metab 94 1732 1739 19223521 10.1210/jc.2008-2138 1:CAS:528:DC%2BD1MXlvVCqtbo%3D
24. H Yu T Rohan 2000 Role of the insulin-like growth factor family in cancer development and progression J Natl Cancer Inst 92 1472 1489 10995803 10.1093/jnci/92.18.1472 1:CAS:528:DC%2BD3cXntFKqsrw%3D
25. DA Lawlor S Ebrahim GD Smith L Cherry P Watt N Sattar 2008 The association of insulin-like-growth factor 1 (IGF-1) with incident coronary heart disease in women: findings from the prospective British Women's Heart and Health Study Atherosclerosis 201 198 204 18295769 10.1016/j.atherosclerosis. 2007.12.061 1:CAS:528:DC%2BD1cXht1Kltr%2FN
26. D Goodman-Gruen E Barrett-Connor 1997 Epidemiology of insulin-like growth factor-I in elderly men and women: the rancho bernardo study Am J Epidemiol 145 970 976 9169905 1:STN:280:DyaK2szhtlehtA%3D%3D (Pubitemid 27215479)
27. HE Botker C Skjaerbaek UK Eriksen O Schmitz H Orksov 1997 Insulin-like growth factor-I, insulin, and angina pectoris secondary to coronary atherosclerosis, vasospasm, and syndrome X Am J Cardiol 79 961 963 9104913 10.1016/S0002-9149(97)00021-0 1:CAS:528:DyaK2sXivVygu70%3D (Pubitemid 27197933)
28. MS Sandhu 2005 Insulin-like growth factor-l and risk of type 2 diabetes and coronary heart disease: molecular epidemiology Endocr Dev 9 44 54 15879687 10.1159/000085755 1:CAS:528:DC%2BD2MXhtVWgurrL
29. M-A Rowlands J Holly D Gunnell R Gilbert J Donovan J Lane G Marsden S Collin F Hamdy D Neal R Martin 2010 The relation between adiposity throughout the life course and variation in IGFs and IGFBPs: evidence from the ProtecT (Prostate testing for cancer and Treatment) study Cancer Causes Control 21 1842 10.1007/s10552-010-9610-x
30. JM Chan MJ Stampfer E Giovannucci PH Gann J Ma P Wilkinson CH Hennekens M Pollak 1998 Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 563 566 9438850 10.1126/science.279.5350.563 1:CAS:528:DyaK1cXotVOqsg%3D%3D (Pubitemid 28067285)
31. EA Platz MN Pollak MF Leitzmann MJ Stampfer WC Willett E Giovannucci 2005 Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA era Cancer Causes Control 16 255 262 15947877 10.1007/s10552-004-3484-8 (Pubitemid 40897844)
32. J-P Thissen J-M Ketelslegers LE Underwood 1994 Nutritional regulation of the insulin-like growth factors Endocr Rev 15 80 101 8156941 1:CAS:528:DyaK2cXkvVWmtrw%3D (Pubitemid 24058597)
33. M Pollak 2008 Insulin and insulin-like growth factor signalling in neoplasia Nat Rev Cancer 8 915 928 19029956 10.1038/nrc2536 1:CAS:528: DC%2BD1cXhsVWhu7rL